Juergen Loskutov

Dr. Juergen Loskutov is specializing in cancer organoid models at the interface of discovery and clinical development. Since recently joining GSK as Scientific Leader in the NiVP/iBMS, he has rapidly established organoid capabilities, leading cross-functional team to develop, characterize, and apply patient-derived organoids to support oncology asset selection and clinical translation. Dr. Loskutov is recognized for rigorous experimental design, advanced ex vivo modelling, and clear communication of complex scientific concepts to scientific, clinical, and leadership stakeholders. He is committed to high scientific standards and impactful collaboration within GSK’s oncology portfolio.